How to Fill Out California Form JV-220 (w/Examples) + FAQs

California Form JV-220 is the Application for Psychotropic Medication that a treating physician must file to ask the juvenile court for permission to give a dependent or delinquent child psychiatric drugs. The form exists because parents lose the right to consent to these powerful medications once a child is removed under Welfare and Institutions Code §369.5 for dependency cases or §739.5 for delinquency cases, leaving the judge as the only person who can authorize psychotropic treatment.

The stakes are high because California foster youth are prescribed psychotropic medications at nearly three times the rate of other Medicaid-enrolled children, according to a GAO report on foster care psychotropic use. A poorly completed JV-220 delays urgent treatment, triggers court rejection, and can expose prescribers to discipline by the Medical Board, while a well-prepared application protects the child, the caregiver, and the prescribing physician.

• 📋 How to complete every section of JV-220 line by line, including the medical justification box that judges scrutinize most.
• ⚖️ Which California Rules of Court, statutes, and case law (including In re Carl H.) control the authorization process.
• 💊 How dosage ranges, drug classes, and lab monitoring should be described so the court approves on the first try.
• 🧑‍⚖️ How parents, caregivers, minors’ counsel, and the child can object using Form JV-222 and what happens at the contested hearing.
• 🚫 The seven most common filing mistakes that get JV-220 applications denied or kicked back by the clerk.

What Form JV-220 Is and Why It Exists

Form JV-220 is a Judicial Council form adopted under California Rule of Court 5.640 that lets a treating physician request court authorization to administer psychotropic medication to a child who is a ward or dependent of the juvenile court. The form is mandatory statewide, meaning every California county, from Los Angeles to Modoc, must accept the same version without local substitution. The Judicial Council last revised the form in January 2022, and using an outdated edition is one of the fastest ways to have a clerk reject the filing at intake.

The form exists because California law strips the right of medication consent from parents the moment a child is detained, but it does not give that right to social workers, probation officers, or foster parents. Instead, Welfare and Institutions Code §369.5 makes the juvenile court judge the sole decision-maker, balancing the child’s medical need against the well-documented risks of antipsychotics, antidepressants, mood stabilizers, and stimulants. The plain-English idea is simple: powerful brain-altering drugs require a neutral judge to look at the evidence before any pill is given.

The consequence of skipping the JV-220 process is severe. A prescriber who medicates a foster youth without court authorization can face Medical Board discipline under Business and Professions Code §2234, civil liability, and removal from the Medi-Cal panel. A real-world example involves Dr. Patel, a Sacramento County psychiatrist who prescribed risperidone to a 9-year-old dependent without filing JV-220; the dependency court ordered the medication stopped within 24 hours and reported the prescriber to county counsel.

A common misconception is that a parent’s verbal agreement is enough once the case is open. It is not, because parental consent authority transfers to the court at detention, and only a signed JV-219 order from the bench restores anyone’s authority to administer the drug.

Who Must File JV-220

The treating physician, almost always a child and adolescent psychiatrist or a pediatrician with psychiatric training, is the only person who may sign Section 8 of JV-220. Social workers, probation officers, foster parents, and even minors’ counsel cannot complete the medical sections, although they often help gather records and route the form to the court. The California Department of Social Services All-County Letter 16-08 clarifies that the county agency assists with logistics but never substitutes for the prescriber’s clinical judgment.

The consequence of letting a non-prescriber fill out the medical sections is automatic denial under Rule 5.640(d), which requires the application to come from the physician who will administer or supervise the medication. A common mistake is having a nurse practitioner sign without verifying that the NP has independent prescriptive authority and a collaborative agreement consistent with Business and Professions Code §2836.1.

Which Children Are Covered

JV-220 applies to any child who is a dependent of the court under Welfare and Institutions Code §300, a ward under §601 or §602, or a non-minor dependent receiving extended foster care under §11403. The form is not used for voluntarily placed youth whose parents retain consent rights, nor for children in private adoptions finalized before the petition. The age range runs from infancy through age 21 for non-minor dependents, although prescribers should expect heightened judicial skepticism for any child under age 6, consistent with the California Foster Care Psychotropic Medication Performance Measures maintained by the Department of Health Care Services.

Legal Framework Behind JV-220

Federal law sets the floor through 42 U.S.C. §675(5)(D), which requires every state to maintain a protocol for the appropriate use and monitoring of psychotropic medications for foster youth as part of its Title IV-E plan. The federal Children’s Bureau ACYF-CB-IM-12-03 information memorandum tells states to build oversight that includes informed consent, monitoring of side effects, and use of evidence-based practice. California satisfies this federal mandate through the JV-217 through JV-224 form set and the Rule 5.640 framework.

State law layers additional protections on top of the federal floor. Welfare and Institutions Code §369.5 and §739.5 establish exclusive court authority, while Health and Safety Code §124260 permits minors aged 12 and over to consent to outpatient mental health treatment in some non-foster contexts, a distinction that frequently confuses prescribers new to dependency work. The interaction between these statutes means that a 14-year-old foster youth cannot self-consent to Prozac the way a 14-year-old living with parents could.

The leading case is In re Carl H. (2017) 7 Cal.App.5th 1019, where the Court of Appeal held that the juvenile court must make specific findings about medical necessity and least-restrictive alternatives before authorizing antipsychotics. The consequence of Carl H. is practical: a JV-220 that lists only “behavior management” as the reason for risperidone will be denied because the case demands a tighter clinical nexus between diagnosis and drug. A common misconception is that Carl H. applies only to antipsychotics; in practice, judges apply its reasoning to every psychotropic class.

Rule of Court 5.640 in Detail

California Rule of Court 5.640 sets the procedural backbone, including the seven-court-day notice rule, the contents of the application, and the standard for ex parte emergency authorizations. The rule requires the court to rule within seven court days of filing unless an objection is filed, in which case a contested hearing must be set within fourteen days. The plain-English consequence is that a prescriber who files on a Friday afternoon before a holiday week may not get an order until 10 to 12 calendar days later, which is critical to communicate to the placement.

A real-world example involves Dr. Nguyen in Alameda County, who filed JV-220 for a 13-year-old on December 18; the order did not issue until January 4 because of court closures, and the youth went 17 days without a planned medication start. A common misconception is that emergency ex parte authorization under Rule 5.640(h) is routinely available; in fact, judges grant it only on documented evidence of imminent danger, such as active suicidal ideation or psychosis with aggression.

Companion Forms in the JV-220 Family

The JV-220 application does not stand alone, and prescribers should expect the clerk to require the full packet. Form JV-217-INFO gives general information to caregivers, JV-218 is the notice of the application, JV-219 is the actual order signed by the judge, and JV-220(A) is an attachment for additional medications when more than two drugs are requested. JV-221 handles proof of notice, JV-222 is the objection form, JV-223 is the input form for the child, and JV-224 is the statement of the child’s view about medication.

The consequence of filing JV-220 without JV-218 and JV-221 is automatic rejection in most counties, because the court cannot rule without proof that the child, parents, caregiver, and minors’ counsel received notice. A common mistake is forgetting JV-220(A) when the prescriber wants to start a third or fourth concurrent medication, which forces a refile and adds another seven days of delay.

Section-by-Section Walkthrough of JV-220

JV-220 contains eight numbered sections plus a signature block, and every line item carries consequences if completed sloppily. The form is six pages in the current January 2022 edition, and the official fillable PDF on courts.ca.gov should be used rather than a county-modified version. Save the file with the case number in the filename to make e-filing easier in counties that use One Legal or File and ServeXpress.

Caption, Case Number, and Section 1 (Child Information)

The caption at the top requires the court name, branch, and full address, which must match the official court directory. Section 1 asks for the child’s name, date of birth, age, and case number, and the case number must include the correct prefix used by that county; for example, Los Angeles uses “DK” or “CK” for dependency and “VJ” for delinquency. The consequence of using the wrong prefix is a clerk rejection within 24 hours, costing the case a full filing day. A real-world example involves Dr. Garcia, a San Diego psychiatrist who used a generic “JV” prefix; the clerk rejected the filing, and the child waited an extra week for sertraline.

Section 2 (Diagnosis) and Section 3 (Other Treatments Tried)

Section 2 requires the DSM-5-TR diagnosis with ICD-10 codes, not lay descriptions like “anger issues.” Judges trained on Rule 5.640 expect F90.2 Attention-Deficit/Hyperactivity Disorder, combined presentation, not “ADHD-ish behavior.” Section 3 asks what non-medication treatments were tried, including therapy modality, frequency, duration, and outcome, because In re Carl H. requires the court to verify that less restrictive alternatives were considered first. A consequence of leaving Section 3 blank is denial with leave to refile, which is the single most common reason for first-round rejection statewide.

Section 4 (Medication Requested) and Section 5 (Dosage and Schedule)

Section 4 asks for the generic name, brand name, drug class, and FDA approval status for the requested age, and the prescriber must check whether use is on-label or off-label under 21 U.S.C. §396. Off-label use is legal but requires a more detailed justification because most psychotropics for children under 6 are off-label. Section 5 asks for starting dose, target dose, maximum dose, frequency, route, and duration of the authorization, which usually runs 180 days under Rule 5.640(g)(2). A consequence of requesting an open-ended duration is automatic reduction to 180 days by the judge, sometimes with a stern minute order.

Section 6 (Medical Necessity) and Section 7 (Risks and Benefits)

Section 6 is the heart of the application and is where most denials originate. The prescriber must explain in plain language why this specific medication, at this specific dose, for this specific child, is medically necessary, and must tie the explanation to the diagnosis in Section 2. Section 7 must list the known risks (weight gain, metabolic syndrome, suicidal ideation in adolescents on SSRIs per the FDA black box warning), expected benefits, and the monitoring plan including labs such as fasting glucose, lipid panel, prolactin, and AIMS scoring for tardive dyskinesia.

A real-world example involves Dr. Lee in Santa Clara County, who wrote in Section 6 that aripiprazole was “for irritability associated with autism spectrum disorder, FDA-approved for ages 6-17, after eight weeks of failed parent-child interaction therapy and a trial of guanfacine.” The judge signed the JV-219 the same day. A common misconception is that the prescriber can attach a journal article and skip Section 6; the rule requires a narrative in the prescriber’s own words.

Section 8 (Physician Signature and Declaration)

Section 8 is the declaration under penalty of perjury, executed under Code of Civil Procedure §2015.5, with the prescriber’s full name, license number, DEA number if applicable, address, and signature with date and city of execution. The consequence of an unsigned or wet-signature-only filing in an e-filing county is rejection, because most California superior courts now require conformed electronic signatures under Rule 2.257.

Three Common Scenarios

Clinical Situation	Filing Path
Stable 10-year-old dependent with new ADHD diagnosis needing methylphenidate	Standard JV-220 with seven-court-day notice; expect routine approval if Section 3 documents behavioral therapy first
15-year-old non-minor dependent in active psychosis with command hallucinations	Ex parte JV-220 under Rule 5.640(h) with declaration of imminent harm; order often signed within 24 hours
8-year-old with autism and severe self-injury already on guanfacine, adding risperidone	JV-220 plus JV-220(A) for concurrent medications; expect set hearing because antipsychotic in young child triggers heightened review

Three Named Examples

Dr. Ramirez, a Los Angeles County child psychiatrist, files JV-220 for Jacob, a 12-year-old dependent with major depressive disorder, recurrent, moderate (F33.1), requesting fluoxetine 10 mg with target 20 mg over six weeks. She documents twelve weeks of cognitive behavioral therapy with the UCLA Trauma-Informed CBT protocol and discloses the FDA black box warning for adolescent SSRIs. The judge signs JV-219 in five court days.

Dr. Okafor, a Fresno County pediatric psychiatrist, files JV-220 plus JV-220(A) for Maya, a 7-year-old with autism spectrum disorder and disruptive mood dysregulation. He requests aripiprazole 2 mg with a target of 5 mg, plus continuation of guanfacine ER 1 mg, and attaches a metabolic monitoring plan citing the American Academy of Child and Adolescent Psychiatry practice parameter. The court sets a contested hearing because the child is under 8.

Dr. Bennett, a probation-contracted psychiatrist in Riverside County, files an ex parte JV-220 for Tyrone, a 16-year-old §602 ward in juvenile hall with acute manic psychosis. She requests olanzapine 5 mg IM stat, then 10 mg PO daily, citing imminent risk of harm under Rule 5.640(h). The duty judge signs the JV-219 within four hours.

Notice, Service, and Filing Logistics

Rule 5.640(c) requires service of JV-220, JV-218, and JV-217-INFO on the child if age 12 or older, the parents whose rights are not terminated, the current caregiver, the social worker or probation officer, the child’s CASA if appointed, and minors’ counsel at least seven court days before the order issues. Service is by personal delivery, first-class mail, or e-service through the court’s electronic filing system. The consequence of skipping service on the caregiver is automatic denial because the caregiver administers the medication and must have a chance to object.

A real-world example involves Dr. Singh in Contra Costa County, who served everyone except the resource family agency caseworker; the judge denied without prejudice and the application had to be refiled with corrected proof of service on JV-221. A common misconception is that email service is automatic; it requires the recipient’s prior written consent under Code of Civil Procedure §1010.6.

E-Filing County by County

Mandatory e-filing applies in Los Angeles, Orange, San Diego, Sacramento, Alameda, Santa Clara, San Francisco, and most large counties, while smaller counties such as Sierra and Alpine still accept paper. Each county publishes its own Local Rules that may add page-numbering, font, and bookmarking requirements. The consequence of submitting an unbookmarked PDF in Los Angeles is rejection under Local Rule 3.4, costing another filing day.

Timing and the Seven-Court-Day Rule

Court days exclude weekends and judicial holidays listed in Government Code §6700. A JV-220 filed on the Monday before Thanksgiving will not ripen for ruling until the following week because Thursday and Friday are court holidays. A common mistake is promising the foster parent that medication will start “next Monday” without checking the court calendar against the Judicial Council’s holiday schedule.

How Objections Work

Any party served with JV-220 may object by filing Form JV-222 within seven court days, which automatically converts the matter to a contested hearing under Rule 5.640(e). The child can also file JV-223 to request a hearing or JV-224 to share views without forcing a hearing. The court must hold the contested hearing within fourteen calendar days of the objection unless the objector waives time.

The consequence of an objection is that the prescriber must usually testify, and the burden remains on the petitioner to show by clear and convincing evidence that the medication is medically necessary and that less intrusive alternatives were tried or are inappropriate. A real-world example involves Dr. Hayes in Sacramento, who faced an objection from a 14-year-old who wanted to try therapy first; the court denied the application and ordered an updated psychological evaluation before reconsidering. A common misconception is that the foster youth’s objection is just a formality; in fact, the California Foster Youth Bill of Rights gives the youth a real voice that judges take seriously.

Mistakes to Avoid

• Using an outdated form edition. The Judicial Council updated JV-220 in January 2022, and earlier versions are rejected at intake; always download from the current forms page.
• Listing only “behavior management” in Section 6. Judges following Carl H. require a clinical nexus to the diagnosis, and vague behavioral language triggers denial.
• Omitting Section 3 alternatives tried. Rule 5.640(d)(3) demands documentation of less-restrictive treatments; a blank Section 3 is the leading cause of first-round denial.
• Filing without JV-218 and JV-221. The court cannot rule without proof of notice, and clerks reject incomplete packets in most counties within 24 hours.
• Requesting more than 180 days. Rule 5.640(g)(2) caps authorization at 180 days, and over-asking flags the application as non-compliant.
• Letting a non-physician sign Section 8. Only the treating physician (or NP with proper authority) may sign; a social worker signature voids the entire application.
• Forgetting JV-220(A) for concurrent medications. Adding a third or fourth drug without the attachment forces a refile and another seven-day clock.
• Ignoring metabolic monitoring in Section 7. Antipsychotic requests without a labs plan invite denial under the AACAP practice parameter standard.
• Missing the e-signature rule. Wet-signature-only filings are rejected in mandatory e-filing counties under Rule 2.257.
• Promising start dates without checking the court calendar. Holidays extend the seven-court-day clock and frustrate caregivers if not anticipated.

Do’s and Don’ts for Prescribers

• Do use DSM-5-TR diagnoses with ICD-10 codes because judges expect clinical precision tied to the diagnostic manual.
• Do document non-medication trials in Section 3 because In re Carl H. makes least-restrictive-alternative analysis a legal requirement.
• Do include FDA approval status because off-label requests need the extra justification or they read as careless.
• Do attach a metabolic monitoring plan because antipsychotics without labs trigger denial under modern standards of care.

• Do serve the caregiver early because their objection rights are real and skipping them voids the order.

• Don’t copy and paste justifications from prior cases because boilerplate language signals to judges that the prescriber did not individualize the assessment.

• Don’t request open-ended durations because the court will reduce them to 180 days and may issue a critical minute order.
• Don’t submit the application without reviewing the most recent court report because outdated placement information leads to service errors.
• Don’t rely on verbal parental consent because parental authority transferred to the court at detention.
• Don’t start the medication before receiving a signed JV-219 because doing so exposes the prescriber to Medical Board discipline.

Pros and Cons of the JV-220 Process

• Pro: Centralized oversight protects youth because a neutral judge balances clinical need against documented harms of psychotropic over-prescribing.
• Pro: Standardized statewide form reduces variation between counties and makes training easier for new dependency prescribers.
• Pro: Mandatory disclosure of alternatives forces consideration of therapy, parent training, and skill-building before drug initiation.
• Pro: Built-in monitoring through 180-day cap ensures regular reassessment and prevents indefinite prescriptions.

• Pro: Youth voice through JV-223 and JV-224 aligns with adolescent autonomy values and the Foster Youth Bill of Rights.

• Con: Seven-court-day delay can postpone urgent treatment, especially around holidays, sometimes worsening symptoms.

• Con: Paperwork burden discourages psychiatrists from accepting foster youth, contributing to the access shortage documented by the Children Now Scorecard.
• Con: Variable judicial expertise means some bench officers approve liberally while others apply stringent Carl H. analysis, creating inconsistent outcomes.
• Con: Service complexity with up to seven required recipients leads to frequent rejections for technical defects.
• Con: Limited emergency pathway because ex parte relief under Rule 5.640(h) is granted sparingly even when symptoms are acute.

Recap of Key Rulings

In re Carl H. (2017) 7 Cal.App.5th 1019 requires the juvenile court to make specific medical-necessity findings before authorizing antipsychotics and is the most-cited case in modern JV-220 practice. In re H.E. (2008) 169 Cal.App.4th 710 addressed due process in psychotropic authorization and confirmed that parents retain a procedural right to notice even when their consent authority has transferred. In re Christopher I. (2003) 106 Cal.App.4th 533 reinforced that the best-interest standard applies across medical decisions for dependents, including pharmacological intervention.

The federal backdrop comes from Parham v. J.R. (1979) 442 U.S. 584, which held that a neutral fact-finder must review involuntary psychiatric treatment of minors, supplying the constitutional foundation for California’s court-authorization scheme. The consequence of these decisions is that JV-220 is not merely administrative paperwork but a constitutionally required due-process step.

Frequently Asked Questions

Can a foster parent consent to psychotropic medication for a foster child?

No. Once a child is detained under WIC §369.5, only the juvenile court judge can authorize psychotropic medication, and the foster parent’s role is to administer the drug after the JV-219 order signs.

Does Form JV-220 cover non-psychotropic medications?

No. JV-220 is limited to psychotropic medications as defined in Rule 5.640(a)(2), and ordinary medications such as antibiotics or asthma inhalers fall under the general medical consent authority of the social worker or probation officer.

Is parental consent ever sufficient in a dependency case?

No. Detention transfers consent authority to the court, so even a fully cooperative parent cannot authorize psychiatric medication without the JV-219 order signed by a judge.

Can a 14-year-old foster youth refuse psychotropic medication?

Yes. The youth can file JV-222 or JV-223 to object or request a hearing, and the court must consider the child’s stated views before ruling.

Does the JV-220 order expire automatically?

Yes. Most orders are limited to 180 days under Rule 5.640(g)(2), and the prescriber must file a new JV-220 to continue the medication beyond that authorization period.

Can a nurse practitioner sign Section 8?

Yes. A psychiatric NP with prescriptive authority and a valid collaborative agreement under Business and Professions Code §2836.1 may sign, but a registered nurse or licensed clinical social worker may not.

Is ex parte emergency authorization realistic?

Yes. Rule 5.640(h) allows emergency relief when there is documented imminent risk of harm, but the prescriber must submit a sworn declaration, and judges grant it sparingly.

Does an objection automatically deny the application?

No. An objection converts the matter to a contested hearing under Rule 5.640(e) within fourteen days, and the court rules after taking evidence rather than denying outright.

Can JV-220 be filed in delinquency cases too?

Yes. WIC §739.5 extends the same court-authorization framework to §602 wards, and the form is identical for dependency and delinquency.

Is e-filing required statewide?

No. Mandatory e-filing applies in most large counties such as Los Angeles, Orange, and San Diego, but smaller counties still accept paper, so check the local rules before filing.

Can the same JV-220 cover multiple medications?

Yes. The base form holds two medications, and additional drugs go on JV-220(A), which must be filed together to avoid a clerk rejection.

Does Medi-Cal cover medications authorized by JV-220?

Yes. Medi-Cal covers court-authorized psychotropic medications for foster youth under the DHCS Foster Care Medi-Cal program, provided the prescriber is enrolled in the Medi-Cal Rx network.